Vasculitis, Central Nervous System: Clinical Trials

159 trials for Vasculitis, Central Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

65 completed, 40 recruiting, 18 unknown, 13 terminated. 24 Phase 2, 19 Phase 3, 15 Not applicable, 9 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 224Completed 12, Recruiting 4, Terminated 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 319Completed 9, Active not recruiting 3, Terminated 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Not applicable15Completed 7, Not yet recruiting 2, Recruiting 2, Unknown 2, Terminated 1, Withdrawn 1
Phase 19Completed 7, Terminated 2
Phase 46Recruiting 2, Unknown 2, Completed 1, Enrolling by invitation 1
Early Phase 11Unknown 1

Follow Vasculitis, Central Nervous System: new trials by email Literature Review of Vasculitis, Central Nervous System trials Research Report on Vasculitis, Central Nervous System

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.
[18F]FDG Long-Axial Field of View (LAFOV)-PET/CT, CT Angiogram, MR Angiogram - Large Vessel Vasculitis, Takayasu Arteritis
Not applicableNot yet recruitingImperial College London182026-12-012026-10-16
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Bedside quantitative sensory testing - Rheumatic Diseases, Lupus Erythematosus, Systemic
Not yet recruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2252026-10-282026-10-23
Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)
Zirconium Zr 89 labelled rituximab - Giant Cell Arteritis (GCA)
Not yet recruitingUniversity of Edinburgh302026-10-012026-06-16
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Pericarditis, Tako-TSUBO Cardiomyopathy
Not yet recruitingAssistance Publique - Hôpitaux de Paris3002026-09-012026-08-10
Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
Prednisone - Giant Cell Arteritis (GCA)
Phase 3Not yet recruitingInsel Gruppe AG, University Hospital Bern1782026-07-012026-05-01
Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)
Blood tests to measure CRP - Giant Cell Arteritis (GCA)
Not applicableNot yet recruitingUniversity Hospital, Limoges402026-06-222026-07-22
Bosentan in the Treatment of Giant Cell Arteritis
Bosentan, Glucocorticoids - Giant Cell Arteritis (GCA)
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris402026-06-012026-05-06
Disease Activity Monitoring in Patients With Giant Cell Arteritis Study
Giant Cell Arteritis (GCA)
RecruitingUniversity of Aarhus1752026-05-062026-08-31
Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA
Optic Nerve Sheath Ultrasound, Temporal artery ultrasound, Bloodwork : CRP and ESR - Giant Cell Arteritis, Temporal Arteritis
RecruitingCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal602026-05-012026-10-21
The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.
Giant Cell Arteritis (GCA)
RecruitingVastra Gotaland Region3402026-03-012026-04-15
Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
Giant Cell Arteritis (GCA)
Not yet recruitingGroupe français d'étude des Maladies Inflammatoires de loeil802026-03-012026-01-21
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
Doppler Ultrasound - Giant Cell Arteritis (GCA), Doppler Ultrasound
Not applicableRecruitingCentre Hospitalier le Mans642026-02-272026-07-17
Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
Description of population - Giant Cell Arteritis (GCA), Spondylarthritis
Not yet recruitingHôpital NOVO102026-02-012026-02-06
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
Positron Emission Tomography / Magnetic Resonance Imaging - Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy
RecruitingCopenhagen University Hospital, Rigshospitalet1222026-01-142026-05-07
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
Tocilizumab, Discontinue Tocilizumab - Giant Cell Arteritis (GCA)
Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)782026-01-052026-08-10
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease
Phase 2RecruitingNYU Langone Health802025-12-122026-07-09
Giant Cell Arteritis - Ways to Precision Medicine
Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)
RecruitingWuerzburg University Hospital4002025-11-142025-12-22
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
orbital ultrasound - Giant Cell Arteritis (GCA)
Not applicableRecruitingHôpital NOVO1902025-09-042025-09-12
Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
Optic nerve sheath ultrasound, Standardized GCA assessment - Giant Cell Arteritis, Anterior Ischemic Optic Neuropathy
RecruitingCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal2852025-08-092026-10-21
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
Giant Cell Arteritis
RecruitingUniversity Hospital, Brest1002025-08-052026-03-20

Showing 20 of 159. Sign in to see all of them.

Narrower conditions

Giant Cell Arteritis (145)  ·  Polymyalgia Rheumatica (24)  ·  Takayasu Arteritis (24)  ·  Vasculitis (23)  ·  Arthritis, Rheumatoid (16)  ·  Granulomatosis with Polyangiitis (16)  ·  Polyarteritis Nodosa (15)  ·  Churg-Strauss Syndrome (12)  ·  Lupus Erythematosus, Systemic (12)  ·  Microscopic Polyangiitis (12)  ·  Behcet Syndrome (10)  ·  Arthritis, Psoriatic (9)  ·  IgA Vasculitis (9)  ·  Arthritis, Juvenile (7)

Broader conditions

Brain Diseases (159)  ·  Central Nervous System Diseases (159)  ·  Nervous System Diseases (159)  ·  Cerebrovascular Disorders (158)  ·  Autoimmune Diseases of the Nervous System (157)  ·  Cardiovascular Diseases (157)  ·  Vascular Diseases (157)  ·  Immune System Diseases (156)  ·  Autoimmune Diseases (154)  ·  Skin and Connective Tissue Diseases (154)  ·  Skin Diseases (148)  ·  Skin Diseases, Vascular (146)  ·  Arteritis (142)  ·  Vasculitis (136)

Interventions

tocilizumab (13)  ·  Prednisone (10)  ·  Blood Specimen Collection (5)  ·  secukinumab (5)  ·  Abatacept (4)  ·  Adrenal Cortex Hormones (4)  ·  Glucocorticoids (4)  ·  Methotrexate (4)  ·  Infliximab (3)  ·  Magnetic Resonance Imaging (3)  ·  Surveys and Questionnaires (3)  ·  Ultrasonography (3)  ·  upadacitinib (3)  ·  Adalimumab (2)  ·  Antilymphocyte Serum (2)

Sponsors

Centre Hospitalier Universitaire Dijon (10)  ·  University of Pennsylvania (9)  ·  University of Bonn (5)  ·  University of South Florida (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Insel Gruppe AG, University Hospital Bern (4)  ·  Novartis Pharmaceuticals (4)  ·  University Hospital, Brest (4)  ·  University Hospital, Caen (4)  ·  University of Aarhus (4)  ·  University of Oxford (4)  ·  Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (3)  ·  Fondation Ophtalmologique Adolphe de Rothschild (3)  ·  Groupe français d'étude des Maladies Inflammatoires de loeil (3)  ·  Hoffmann-La Roche (3)

Countries

France (54)  ·  United States (47)  ·  Canada (23)  ·  Germany (23)  ·  Denmark (19)  ·  United Kingdom (17)  ·  Switzerland (14)  ·  Italy (12)  ·  Spain (11)  ·  Belgium (10)  ·  Australia (9)  ·  Netherlands (9)  ·  Sweden (8)  ·  Poland (7)  ·  Portugal (7)

Top investigators

Peter A Merkel, MD, MPH (5)  ·  Peter A. Merkel, MD, MPH (5)  ·  Amanda M. Terry, MA (3)  ·  Raashid A Luqmani, DM FRCP (3)  ·  Ann Morgan (2)  ·  Megan Clowse, MD, MPH (2)  ·  Peter C. Grayson, MD (2)  ·  Peter Merkel, MD, MPH (2)  ·  Salome Kristensen, MD, PhD (2)  ·  Alessandro Invernizzi, Prof. (1)

Results publications

PMID 26952547, PMID 28745999, PMID 32866179, PMID 14558057, PMID 16914703, PMID 17407214, PMID 17470830, PMID 17557758, PMID 19955046, PMID 20813797, PMID 21743987, PMID 21873264, PMID 22674883, PMID 23528439, PMID 23653652, PMID 23897775, PMID 24046471, PMID 24106211, PMID 24189842, PMID 24529335, PMID 24574239, PMID 24891881, PMID 25396066, PMID 25592534, PMID 25697557, PMID 25902790, PMID 26090367, PMID 27236507, PMID 27940595, PMID 27980877, PMID 28133925, PMID 28133931, PMID 28405470, PMID 28756037, PMID 29961816, PMID 30054122, PMID 30392702, PMID 30786937, PMID 30835950, PMID 30848549, PMID 31270110, PMID 31649025, PMID 31785185, PMID 32248659, PMID 32844378, PMID 33544969, PMID 33942031, PMID 34049857, PMID 34117737, PMID 34404463

NIH funding

2018 (4), 2019 (3), 2023 (3), U54AR057319 (3), 2016 (2), 2017 (2), 2008 (1), 2015 (1), 2025 (1), 268200700036C-5-0-1 (1), R01AR084199 (1)